Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age40-85
SponsorNYU Langone Health

About this trial

This will be a prospectively maintained research database. The purpose is to record baseline parameters and treatment outcomes following of Cryotherapy for ablation of clinically localized prostate cancer.

Eligibility criteria

Qualifiers

Evidence of focal prostate cancer confined to the prostate based on MRI imaging and prostate biopsy

Patients with clinically localized prostate cancer (no evidence for or concern for metastatic spread of cancer outside of the prostate) will be counseled regarding treatment options. Those selecting focal Cryo prostate ablation will then be offered inclusion into this data collection.

Disqualifiers

Men that are not diagnosed with prostate cancer.

Men that are diagnosed with clinically localized prostate cancer, but select other treatment options as their desired treatment.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,000 Participants
are grouped into 1 trial group

Sponsors and collaborators